Dexcom Q4 revenue $1.26B beats high end; FY2026 outlook $5.16-5.25B; new CEO Jake Leach

DEXCOM INC

2025-FY EPS reported $2.09 revenue$4,662,000,000

Q4 total revenue ~$1.260B (+13% YoY), US $892M (+11%), Intl $368M (+18%).
FY2025 revenue ~$4.662B (+16%); reiterates non-GAAP gross margin ~61%, operating margin 20-21%.
FY2026 revenue guidance $5.16-5.25B (+11-13%); non-GAAP gross margin 63-64%, operating margin 22-23%.
Jake Leach assumed CEO role Jan 1, 2026, succeeding Kevin Sayer; presents at JPM conference.
Stelo app reimagined with AI; G7 15 Day system shipping to pharmacies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.